Physician profile
Jaime Yun
NPI 1073550232
$633.75
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $110 · 2021: $207 · 2022: $99.58.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $132.37 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.15 | 2019 | |
| Bard Access Systems, INC. | $71.54 | 2019 | |
| Smith+Nephew, INC. | $65.58 | 2022 | |
| W. L. Gore & Associates, INC. | $46.95 | 2021 | |
| Gotham Surgical Solutions & Devices, INC. | $44.23 | 2020 | |
| Kls-Martin L.P. | $40.34 | 2020 | |
| Medical Device Business Services, INC. | $34.00 | 2022 | |
| Acell, INC. | $24.45 | 2019 | |
| Atricure, INC. | $15.81 | 2021 | |
| Zimmer Biomet Holdings, INC. | $13.30 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $12.15 | 2020 | |
| Teleflex LLC | $11.88 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Yun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.